Investigation of the in vitro therapeutic efficacy of nilotinib in immortalized human NF2-null vestibular schwannoma cells.

Investigation of the in vitro therapeutic efficacy of nilotinib in immortalized human NF2-null vestibular schwannoma cells.

Vestibular schwannomas (VS) are a common posterior fossa brain tumor, and though benign can cause significant morbidity, particularly loss of hearing, tinnitus, vertigo and facial paralysis. The current treatment options for VS include microsurgical resection, stereotactic radiosurgery or close surv...

Full description

Bibliographic Details
Main Authors: Nesrin Sabha, Karolyn Au, Sameer Agnihotri, Sanjay Singh, Rupinder Mangat, Abhijit Guha, Gelareh Zadeh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3379978?pdf=render

Internet

http://europepmc.org/articles/PMC3379978?pdf=render

Similar Items